Oncothyreon Revenue
Biotechnology Research • 
United States • 1-10 Employees
$
Oncothyreon revenue & valuation
| Annual revenue | $3,500,000,000 |
| Revenue per employee | $437,500,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,200,000,000 |
| Total funding | No funding |
Key Contact at Oncothyreon
John Wolfgang
Managing Director
Company overview
| Headquarters | United States |
| Websites | |
| NAICS | 541714 |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
About Oncothyreon
Oncothyreon is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. We are currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. Our pipeline includes both synthetic vaccines and small molecules for a variety of cancer indications.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Entry
C-Suite
Manager
Employees by Department
Oncothyreon has 7 employees across 5 departments.
Departments
Number of employees
Funding Data
Oncothyreon has never raised funding before.
Saudi Arabia
China
Australia
PolandFrequently asked questions
Oncothyreon is located in US.
Oncothyreon generates an estimated annual revenue of $3,500,000,000. This revenue figure reflects the company's market position and business performance in its industry.
Oncothyreon has an estimated valuation of $11,200,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Oncothyreon has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
